DK3081097T3 - Sammensætning til behandling af infertilitet - Google Patents

Sammensætning til behandling af infertilitet Download PDF

Info

Publication number
DK3081097T3
DK3081097T3 DK16171147.8T DK16171147T DK3081097T3 DK 3081097 T3 DK3081097 T3 DK 3081097T3 DK 16171147 T DK16171147 T DK 16171147T DK 3081097 T3 DK3081097 T3 DK 3081097T3
Authority
DK
Denmark
Prior art keywords
composition
treating infertility
infertility
treating
Prior art date
Application number
DK16171147.8T
Other languages
English (en)
Inventor
Luigi Amelotti
Lorenzo Secondini
Original Assignee
Uriach Italy S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43736968&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3081097(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Uriach Italy S R L filed Critical Uriach Italy S R L
Application granted granted Critical
Publication of DK3081097T3 publication Critical patent/DK3081097T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK16171147.8T 2010-12-17 2011-12-19 Sammensætning til behandling af infertilitet DK3081097T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2010A002313A IT1403587B1 (it) 2010-12-17 2010-12-17 Composizione per il trattamento di disordini metabolici
EP11813358.6A EP2651251B1 (en) 2010-12-17 2011-12-19 Composition for the treatment of infertility

Publications (1)

Publication Number Publication Date
DK3081097T3 true DK3081097T3 (da) 2020-01-20

Family

ID=43736968

Family Applications (2)

Application Number Title Priority Date Filing Date
DK11813358.6T DK2651251T3 (da) 2010-12-17 2011-12-19 Sammensætning til behandling af infertilitet
DK16171147.8T DK3081097T3 (da) 2010-12-17 2011-12-19 Sammensætning til behandling af infertilitet

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK11813358.6T DK2651251T3 (da) 2010-12-17 2011-12-19 Sammensætning til behandling af infertilitet

Country Status (12)

Country Link
EP (2) EP2651251B1 (da)
BR (1) BR112013015048A2 (da)
DK (2) DK2651251T3 (da)
ES (2) ES2586930T3 (da)
HR (1) HRP20160978T1 (da)
HU (2) HUE047320T2 (da)
IT (1) IT1403587B1 (da)
PL (2) PL3081097T3 (da)
PT (2) PT2651251T (da)
RS (1) RS55057B1 (da)
RU (1) RU2586742C2 (da)
WO (1) WO2012080831A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102834096A (zh) 2010-01-14 2012-12-19 卢福研究公司 用于疼痛控制的固态成型局部麻醉制剂
ITMI20130349A1 (it) * 2013-03-07 2014-09-08 Laborest Italia S P A Composizione per uso nel trattamento della sindrome dell ovaio policistico
ITUA20163025A1 (it) 2016-04-29 2017-10-29 Sochim Int S P A Composizione per il trattamento della sindrome dell’ovaio policistico
US11898184B2 (en) 2017-09-07 2024-02-13 Sweet Sense Inc. Low glycemic sugar composition
WO2020112699A1 (en) 2018-11-26 2020-06-04 The Procter & Gamble Company Solid pharmaceutical preparation containing lipoic acid and use thereof
RU2757220C1 (ru) * 2020-06-03 2021-10-12 Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" Фармацевтическая композиция для профилактики и лечения синдрома поликистозных яичников

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2152787C2 (ru) * 1994-06-02 2000-07-20 Дан Рига Лекарство против стресса, против снижения уровня активности и против старения и способ его получения
US20020155163A1 (en) * 1999-12-27 2002-10-24 Samuel D. Benjamin Integrated multi-vitamin and mineral combination
US20040043013A1 (en) * 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
US20070065456A1 (en) * 2005-09-20 2007-03-22 Woods Cindy J Nutritional supplements

Also Published As

Publication number Publication date
ITMI20102313A1 (it) 2012-06-18
EP3081097B8 (en) 2020-01-08
RU2586742C2 (ru) 2016-06-10
EP3081097B1 (en) 2019-12-04
ES2763437T3 (es) 2020-05-28
PL3081097T3 (pl) 2020-06-15
EP2651251A1 (en) 2013-10-23
IT1403587B1 (it) 2013-10-31
RU2013130308A (ru) 2015-01-27
PL2651251T3 (pl) 2017-06-30
PT2651251T (pt) 2016-08-19
ES2586930T3 (es) 2016-10-19
DK2651251T3 (da) 2016-09-05
HUE047320T2 (hu) 2020-04-28
HRP20160978T1 (hr) 2016-10-07
WO2012080831A1 (en) 2012-06-21
EP3081097A1 (en) 2016-10-19
HUE029493T2 (en) 2017-02-28
PT3081097T (pt) 2020-01-14
RS55057B1 (sr) 2016-12-30
BR112013015048A2 (pt) 2016-07-19
EP2651251B1 (en) 2016-06-01

Similar Documents

Publication Publication Date Title
SMT201600271B (it) BENZOSSAZEPINONI FUSI COME MODULATORI DI CANALl IONICI
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
DK2709613T4 (da) Fremgangsmåder til behandling af hcv
DK3329775T3 (da) Fremgangsmåder til syntese af diarylthiohydantoin- og diarylhydantoinforbindelser
BR112013022112A2 (pt) composição
BR112013022102A2 (pt) composição
BR112012031667A2 (pt) composição
DK2686017T3 (da) Oftalmisk sammensætning
BR112013017183A2 (pt) composições de bepostatina
DK2699553T3 (da) Substituerede diaminocarboxamid- og diaminocarbonitrilpyrimidiner, sammensætninger deraf og fremgangsmåder til behandling dermed
DK2310034T3 (da) Peptider til behandling af beta-amyloidose
BR112014004395A2 (pt) composição
DK2580156T4 (da) Fremgangsmåde til lagring af hydrogen
DK2364795T3 (da) Coatingsammensætning til støbegods
DK3412687T3 (da) Fremgangsmåder til behandling af dlbcl
DK2585088T3 (da) Sammensætning til forbedring af seksuel sundhed
BR112012032683A2 (pt) composição
DK2526425T3 (da) Fremgangsmåde til diagnosticering af endometriel receptivitet
DK2635282T3 (da) Sammensætninger til behandling af myelofibrose
DK3322183T3 (da) Fremgangsmåde til intraforudsigelse af video
DK2857019T3 (da) Fremgangsmåde til behandling af multipel sklerose
DK2595948T3 (da) Fremgangsmåde til fremstilling af ingenol-3-angelat
BR112014009802A2 (pt) composições de bismaleimida contendo nanossílica
DK3138916T3 (da) Immunogen sammensætning
BR112013033808A2 (pt) composição